!

! 137!

REFERENCES Abe, Masashi, and Nancy M. Bonini. 2013. “MicroRNAs and Neurodegeneration:

Role and Impact.” Trends in Cell Biology 23 (1): 30–36. doi:10.1016/j.tcb.2012.08.013.

Adachi, Naoko, Takeshi Kobayashi, Hideyuki Takahashi, Takumi Kawasaki, Yasuhito Shirai, Takehiko Ueyama, Toshio Matsuda, Takahiro Seki, Norio Sakai, and Naoaki Saito. 2008. “Enzymological Analysis of Mutant Protein Kinase Cgamma Causing Spinocerebellar Ataxia Type 14 and Dysfunction in Ca2+ Homeostasis.” The Journal of Biological Chemistry 283 (28): 19854–63. doi:10.1074/jbc.M801492200.

Airaksinen, Matti S., Jens Eilers, Olga Garaschuk, Hans Thoenen, Arthur Konnerth, and Michael Meyer. 1997. “Ataxia and Altered Dendritic Calcium Signaling in Mice Carrying a Targeted Null Mutation of the Calbindin D28k Gene.” Proceedings of the National Academy of Sciences 94 (4): 1488–93.

Ames, Robert S., Yi Li, Henry M. Sarau, Paru Nuthulaganti, James J. Foley, Catherine Ellis, Zhizhen Zeng, et al. 1996. “Molecular Cloning and Characterization of the Human Anaphylatoxin C3a Receptor.” Journal of Biological Chemistry 271 (34): 20231–34. doi:10.1074/jbc.271.34.20231.

Anders, Simon, Paul Theodor Pyl, and Wolfgang Huber. 2014. “HTSeq – A Python Framework to Work with High-Throughput Sequencing Data.” bioRxiv, February. doi:10.1101/002824.

Arndt, Greg M., Lesley Dossey, Lara M. Cullen, Angela Lai, Riki Druker, Michael Eisbacher, Chunyan Zhang, et al. 2009. “Characterization of Global microRNA Expression Reveals Oncogenic Potential of miR-145 in Metastatic Colorectal Cancer.” BMC Cancer 9: 374. doi:10.1186/1471-2407-9-374.

Arosio, Beatrice, Claudio D’Addario, Cristina Gussago, Martina Casati, Enzo Tedone, Evelyn Ferri, Paola Nicolini, Paolo D. Rossi, Mauro Maccarrone, and Daniela Mari. 2014. “Peripheral Blood Mononuclear Cells as a Laboratory to Study Dementia in the Elderly.” BioMed Research International 2014 (April): e169203. doi:10.1155/2014/169203.

Ashizawa, Tetsuo, Karla P. Figueroa, Susan L. Perlman, Christopher M. Gomez, George R. Wilmot, Jeremy D. Schmahmann, Sarah H. Ying, et al. 2013. “Clinical Characteristics of Patients with Spinocerebellar Ataxias 1, 2, 3 and 6 in the US; a Prospective Observational Study.” Orphanet Journal of Rare Diseases 8: 177. doi:10.1186/1750-1172-8-177.

Avila-Figueroa, Amalia, Douglas Cattie, and Sarah Delaney. 2011. “A Small Unstructured Nucleic Acid Disrupts a Trinucleotide Repeat Hairpin.” Biochemical and Biophysical Research Communications 413 (4): 532–36. doi:10.1016/j.bbrc.2011.08.130.

Bahl, S., K. Virdi, U. Mittal, M. P. Sachdeva, A. K. Kalla, S. E. Holmes, E. O’Hearn, et al. 2005. “Evidence of a Common Founder for SCA12 in the Indian Population.” Annals of Human Genetics 69 (Pt 5): 528–34. doi:10.1046/j.1529-8817.2005.00173.x.

Bakalkin, Georgy, Hiroyuki Watanabe, Justyna Jezierska, Cloë Depoorter, Corien Verschuuren-Bemelmans, Igor Bazov, Konstantin A. Artemenko, et al. 2010. “Prodynorphin Mutations Cause the Neurodegenerative Disorder Spinocerebellar Ataxia Type 23.” The American Journal of Human Genetics 87 (5): 593–603. doi:10.1016/j.ajhg.2010.10.001.

Banfi, S., A. Servadio, M. Chung, F. Capozzoli, L. A. Duvick, R. Elde, H. Y. Zoghbi, and H. T. Orr. 1996a. “Cloning and Developmental Expression Analysis of the

!

! 138!

Murine Homolog of the Spinocerebellar Ataxia Type 1 Gene (Sca1).” Human Molecular Genetics 5 (1): 33–40.

Banfi, S, A Servadio, M Y Chung, T J Kwiatkowski Jr, A E McCall, L A Duvick, Y Shen, E J Roth, H T Orr, and H Y Zoghbi. 1994a. “Identification and Characterization of the Gene Causing Type 1 Spinocerebellar Ataxia.” Nature Genetics 7 (4): 513–20. doi:10.1038/ng0894-513.

Banfi, S., A. Servadio, M. Y. Chung, T. J. Kwiatkowski, A. E. McCall, L. A. Duvick, Y. Shen, E. J. Roth, H. T. Orr, and H. Y. Zoghbi. 1994b. “Identification and Characterization of the Gene Causing Type 1 Spinocerebellar Ataxia.” Nature Genetics 7 (4): 513–20. doi:10.1038/ng0894-513.

Basu, P, B Chattopadhyay, P K Gangopadhaya, S C Mukherjee, K K Sinha, S K Das, S Roychoudhury, P P Majumder, and N P Bhattacharyya. 2000. “Analysis of CAG Repeats in SCA1, SCA2, SCA3, SCA6, SCA7 and DRPLA Loci in Spinocerebellar Ataxia Patients and Distribution of CAG Repeats at the SCA1, SCA2 and SCA6 Loci in Nine Ethnic Populations of Eastern India.” Human Genetics 106 (6): 597–604.

Becanovic, Kristina, Mahmoud A. Pouladi, Raymond S. Lim, Alexandre Kuhn, Paul Pavlidis, Ruth Luthi-Carter, Michael R. Hayden, and Blair R. Leavitt. 2010. “Transcriptional Changes in Huntington Disease Identified Using Genome-Wide Expression Profiling and Cross-Platform Analysis.” Human Molecular Genetics 19 (8): 1438–52. doi:10.1093/hmg/ddq018.

Bergeron, Danny, Catherine Lapointe, Cyntia Bissonnette, Guillaume Tremblay, Julie Motard, and Xavier Roucou. 2013. “An out-of-Frame Overlapping Reading Frame in the Ataxin-1 Coding Sequence Encodes a Novel Ataxin-1 Interacting Protein.” The Journal of Biological Chemistry 288 (30): 21824–35. doi:10.1074/jbc.M113.472654.

Berridge, Michael J. 2010. “Calcium Hypothesis of Alzheimer’s Disease.” Pflügers Archiv: European Journal of Physiology 459 (3): 441–49. doi:10.1007/s00424-009-0736-1.

Bezprozvanny, I. 2007. “Inositol 1,4,5-Tripshosphate Receptor, Calcium Signalling and Huntington’s Disease.” Sub-Cellular Biochemistry 45: 323–35.

Bezprozvanny, Ilya. 2011. “Role of Inositol 1,4,5-Trisphosphate Receptors in Pathogenesis of Huntington’s Disease and Spinocerebellar Ataxias.” Neurochemical Research 36 (7): 1186–97. doi:10.1007/s11064-010-0393-y.

Bezprozvanny, Ilya, and Michael R. Hayden. 2004. “Deranged Neuronal Calcium Signaling and Huntington Disease.” Biochemical and Biophysical Research Communications 322 (4): 1310–17. doi:10.1016/j.bbrc.2004.08.035.

Bezprozvanny, Ilya, and Mark P. Mattson. 2008. “Neuronal Calcium Mishandling and the Pathogenesis of Alzheimer’s Disease.” Trends in Neurosciences 31 (9): 454–63. doi:10.1016/j.tins.2008.06.005.

Bilen, Julide, Nan Liu, Barrington G. Burnett, Randall N. Pittman, and Nancy M. Bonini. 2006a. “MicroRNA Pathways Modulate Polyglutamine-Induced Neurodegeneration.” Molecular Cell 24 (1): 157–63. doi:10.1016/j.molcel.2006.07.030.

Björkqvist, Maria, Edward J. Wild, Jenny Thiele, Aurelio Silvestroni, Ralph Andre, Nayana Lahiri, Elsa Raibon, et al. 2008a. “A Novel Pathogenic Pathway of Immune Activation Detectable before Clinical Onset in Huntington’s Disease.” The Journal of Experimental Medicine 205 (8): 1869–77. doi:10.1084/jem.20080178.

!

! 139!

Bolger, Timothy A., Xuan Zhao, Todd J. Cohen, Chih-Cheng Tsai, and Tso-Pang Yao. 2007. “The Neurodegenerative Disease Protein Ataxin-1 Antagonizes the Neuronal Survival Function of Myocyte Enhancer Factor-2.” Journal of Biological Chemistry 282 (40): 29186–92. doi:10.1074/jbc.M704182200.

Borovecki, F., L. Lovrecic, J. Zhou, H. Jeong, F. Then, H. D. Rosas, S. M. Hersch, et al. 2005a. “Genome-Wide Expression Profiling of Human Blood Reveals Biomarkers for Huntington’s Disease.” Proceedings of the National Academy of Sciences of the United States of America 102 (31): 11023–28. doi:10.1073/pnas.0504921102.

Brini, Marisa, Tito Calì, Denis Ottolini, and Ernesto Carafoli. 2014. “Neuronal Calcium Signaling: Function and Dysfunction.” Cellular and Molecular Life Sciences 71 (15): 2787–2814. doi:10.1007/s00018-013-1550-7.

Bryer, Alan, Amanda Krause, Pierre Bill, Virginia Davids, Daphne Bryant, James Butler, Jeannine Heckmann, Rajkumar Ramesar, and Jacquie Greenberg. 2003a. “The Hereditary Adult-Onset Ataxias in South Africa.” Journal of the Neurological Sciences 216 (1): 47–54.

Buckner, Randy L. 2013. “The Cerebellum and Cognitive Function: 25 Years of Insight from Anatomy and Neuroimaging.” Neuron 80 (3): 807–15. doi:10.1016/j.neuron.2013.10.044.

Bullard, James H., Elizabeth Purdom, Kasper D. Hansen, and Sandrine Dudoit. 2010. “Evaluation of Statistical Methods for Normalization and Differential Expression in mRNA-Seq Experiments.” BMC Bioinformatics 11 (1): 94. doi:10.1186/1471-2105-11-94.

Bürk, K., M. Abele, M. Fetter, J. Dichgans, M. Skalej, F. Laccone, O. Didierjean, A. Brice, and T. Klockgether. 1996a. “Autosomal Dominant Cerebellar Ataxia Type I Clinical Features and MRI in Families with SCA1, SCA2 and SCA3.” Brain: A Journal of Neurology 119 ( Pt 5) (October): 1497–1505.

Butovsky, Oleg, Mark P. Jedrychowski, Craig S. Moore, Ron Cialic, Amanda J. Lanser, Galina Gabriely, Thomas Koeglsperger, et al. 2014. “Identification of a Unique TGF-Β-Dependent Molecular and Functional Signature in Microglia.” Nature Neuroscience 17 (1): 131–43. doi:10.1038/nn.3599.

Cagnoli, Claudia, Caterina Mariotti, Franco Taroni, Marco Seri, Alessandro Brussino, Chiara Michielotto, Marina Grisoli, et al. 2006. “SCA28, a Novel Form of Autosomal Dominant Cerebellar Ataxia on Chromosome 18p11.22–q11.2.” Brain 129 (1): 235–42. doi:10.1093/brain/awh651.

Cahill, Susanne, Paul Smyth, Karen Denning, Richard Flavin, Jinghuan Li, Astrid Potratz, Simone M. Guenther, Richard Henfrey, John J. O’Leary, and Orla Sheils. 2007. “Effect of BRAFV600E Mutation on Transcription and Post-Transcriptional Regulation in a Papillary Thyroid Carcinoma Model.” Molecular Cancer 6: 21. doi:10.1186/1476-4598-6-21.

Chan, Edmond Y. W., Ruth Luthi-Carter, Andrew Strand, Steven M. Solano, Sarah A. Hanson, Molly M. DeJohn, Charles Kooperberg, et al. 2002. “Increased Huntingtin Protein Length Reduces the Number of Polyglutamine-Induced Gene Expression Changes in Mouse Models of Huntington’s Disease.” Human Molecular Genetics 11 (17): 1939–51.

Cheng, Cong, Weiguang Li, Zheng Zhang, Shohei Yoshimura, Qinyu Hao, Chi Zhang, and Zhao Wang. 2013. “MicroRNA-144 Is Regulated by Activator Protein-1 (AP-1) and Decreases Expression of Alzheimer Disease-Related a Disintegrin and Metalloprotease 10 (ADAM10).” The Journal of Biological Chemistry 288 (19): 13748–61. doi:10.1074/jbc.M112.381392.

!

! 140!

Chen, Xian-Ming. 2009. “MicroRNA Signatures in Liver Diseases.” World Journal of Gastroenterology: WJG 15 (14): 1665–72.

Chen, Xi, Tie-Shan Tang, Huiping Tu, Omar Nelson, Mark Pook, Robert Hammer, Nobuyuki Nukina, and Ilya Bezprozvanny. 2008. “Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3.” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 28 (48): 12713–24. doi:10.1523/JNEUROSCI.3909-08.2008.

Chung, Ming-yi, Laura P. W. Ranum, Lisa A. Duvick, Antonio Servadio, Huda Y. Zoghbi, and Harry T. Orr. 1993. “Evidence for a Mechanism Predisposing to Intergenerational CAG Repeat Instability in Spinocerebellar Ataxia Type I.” Nature Genetics 5 (3): 254–58. doi:10.1038/ng1193-254.

Chung, M Y, L P Ranum, L A Duvick, A Servadio, H Y Zoghbi, and H T Orr. 1993a. “Evidence for a Mechanism Predisposing to Intergenerational CAG Repeat Instability in Spinocerebellar Ataxia Type I.” Nature Genetics 5 (3): 254–58. doi:10.1038/ng1193-254.

Chung, M. Y., L. P. Ranum, L. A. Duvick, A. Servadio, H. Y. Zoghbi, and H. T. Orr. 1993b. “Evidence for a Mechanism Predisposing to Intergenerational CAG Repeat Instability in Spinocerebellar Ataxia Type I.” Nature Genetics 5 (3): 254–58. doi:10.1038/ng1193-254.

Chung, Tony K. H., Tak-Hong Cheung, Ngar-Yee Huen, Katherine W. Y. Wong, Keith W. K. Lo, So-Fan Yim, Nelson S. S. Siu, et al. 2009. “Dysregulated microRNAs and Their Predicted Targets Associated with Endometrioid Endometrial Adenocarcinoma in Hong Kong Women.” International Journal of Cancer. Journal International Du Cancer 124 (6): 1358–65. doi:10.1002/ijc.24071.

Clark, H. B., E. N. Burright, W. S. Yunis, S. Larson, C. Wilcox, B. Hartman, A. Matilla, H. Y. Zoghbi, and H. T. Orr. 1997a. “Purkinje Cell Expression of a Mutant Allele of SCA1 in Transgenic Mice Leads to Disparate Effects on Motor Behaviors, Followed by a Progressive Cerebellar Dysfunction and Histological Alterations.” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 17 (19): 7385–95.

Cogswell, John P., James Ward, Ian A. Taylor, Michelle Waters, Yunling Shi, Brian Cannon, Kevin Kelnar, et al. 2008. “Identification of miRNA Changes in Alzheimer’s Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways.” Journal of Alzheimer’s Disease: JAD 14 (1): 27–41.

Cooper-Knock, Johnathan, Janine Kirby, Laura Ferraiuolo, Paul R. Heath, Magnus Rattray, and Pamela J. Shaw. 2012. “Gene Expression Profiling in Human Neurodegenerative Disease.” Nature Reviews. Neurology 8 (9): 518–30. doi:10.1038/nrneurol.2012.156.

Costa, Valerio, Roberta Esposito, Marianna Aprile, and Alfredo Ciccodicola. 2012. “Non-Coding RNA and Pseudogenes in Neurodegenerative Diseases: ‘The (un)Usual Suspects.’” Frontiers in Genetics 3: 231. doi:10.3389/fgene.2012.00231.

Coutinho, P., and C. Andrade. 1978. “Autosomal Dominant System Degeneration in Portuguese Families of the Azores Islands. A New Genetic Disorder Involving Cerebellar, Pyramidal, Extrapyramidal and Spinal Cord Motor Functions.” Neurology 28 (7): 703–9.

Crawford, Melissa, Kara Batte, Lianbo Yu, Xin Wu, Gerard J. Nuovo, Clay B. Marsh, Gregory A. Otterson, and Serge P. Nana-Sinkam. 2009. “MicroRNA 133B Targets pro-Survival Molecules MCL-1 and BCL2L2 in Lung Cancer.”

!

! 141!

Biochemical and Biophysical Research Communications 388 (3): 483–89. doi:10.1016/j.bbrc.2009.07.143.

Crespo-Barreto, Juan, John D. Fryer, Chad A. Shaw, Harry T. Orr, and Huda Y. Zoghbi. 2010. “Partial Loss of Ataxin-1 Function Contributes to Transcriptional Dysregulation in Spinocerebellar Ataxia Type 1 Pathogenesis.” PLoS Genetics 6 (7): e1001021. doi:10.1371/journal.pgen.1001021.

Cvetanovic, Marija, Jay M. Patel, Hugo H. Marti, Ameet R. Kini, and Puneet Opal. 2011. “Vascular Endothelial Growth Factor Ameliorates the Ataxic Phenotype in a Mouse Model of Spinocerebellar Ataxia Type 1.” Nature Medicine 17 (11): 1445–47. doi:10.1038/nm.2494.

Dai, Yong, Weiguo Sui, Huijuan Lan, Qiang Yan, He Huang, and YuanShuai Huang. 2009. “Comprehensive Analysis of microRNA Expression Patterns in Renal Biopsies of Lupus Nephritis Patients.” Rheumatology International 29 (7): 749–54. doi:10.1007/s00296-008-0758-6.

Dauchy, Sandrine, Fabien Dutheil, Richard J. Weaver, Francine Chassoux, Catherine Daumas-Duport, Pierre-Olivier Couraud, Jean-Michel Scherrmann, Isabelle De Waziers, and Xavier Declèves. 2008. “ABC Transporters, Cytochromes P450 and Their Main Transcription Factors: Expression at the Human Blood-Brain Barrier.” Journal of Neurochemistry 107 (6): 1518–28. doi:10.1111/j.1471-4159.2008.05720.x.

Desikan, Rahul S., Wesley K. Thompson, Dominic Holland, Christopher P. Hess, James B. Brewer, Henrik Zetterberg, Kaj Blennow, et al. 2014. “The Role of Clusterin in Amyloid-Β Associated Neurodegeneration.” JAMA Neurology 71 (2): 180–87. doi:10.1001/jamaneurol.2013.4560.

DeStefano, Anita L, Mark F Lew, Lawrence I Golbe, Margery H Mark, Alice M Lazzarini, Mark Guttman, Erwin Montgomery, et al. 2002. “PARK3 Influences Age at Onset in Parkinson Disease: A Genome Scan in the GenePD Study.” American Journal of Human Genetics 70 (5): 1089–95. doi:10.1086/339814.

Dijkstra, Ineke M., Sandra Hulshof, Paul van der Valk, Hendrikus W. G. M. Boddeke, and Knut Biber. 2004. “Cutting Edge: Activity of Human Adult Microglia in Response to CC Chemokine Ligand 21.” The Journal of Immunology 172 (5): 2744–47. doi:10.4049/jimmunol.172.5.2744.

Doss, Sarah, Alexander U Brandt, Timm Oberwahrenbrock, Matthias Endres, Friedemann Paul, and Jan Leo Rinnenthal. 2013. “Metabolic Evidence for Cerebral Neurodegeneration in Spinocerebellar Ataxia Type 1.” Cerebellum (London, England), October. doi:10.1007/s12311-013-0527-2.

Doss, Sarah, Alexander U. Brandt, Timm Oberwahrenbrock, Matthias Endres, Friedemann Paul, and Jan Leo Rinnenthal. 2014. “Metabolic Evidence for Cerebral Neurodegeneration in Spinocerebellar Ataxia Type 1.” Cerebellum (London, England) 13 (2): 199–206. doi:10.1007/s12311-013-0527-2.

Dubourg, O., A. Dürr, G. Cancel, G. Stevanin, H. Chneiweiss, C. Penet, Y. Agid, and A. Brice. 1995. “Analysis of the SCA1 CAG Repeat in a Large Number of Families with Dominant Ataxia: Clinical and Molecular Correlations.” Annals of Neurology 37 (2): 176–80. doi:10.1002/ana.410370207.

Dürr, A., H. Chneiweiss, C. Khati, G. Stevanin, G. Cancel, J. Feingold, Y. Agid, and A. Brice. 1993. “Phenotypic Variability in Autosomal Dominant Cerebellar Ataxia Type I Is Unrelated to Genetic Heterogeneity.” Brain: A Journal of Neurology 116 ( Pt 6) (December): 1497–1508.

!

! 142!

Duyao, M., C. Ambrose, R. Myers, A. Novelletto, F. Persichetti, M. Frontali, S. Folstein, C. Ross, M. Franz, and M. Abbott. 1993. “Trinucleotide Repeat Length Instability and Age of Onset in Huntington’s Disease.” Nature Genetics 4 (4): 387–92. doi:10.1038/ng0893-387.

ElSharawy, Abdou, Andreas Keller, Friederike Flachsbart, Anke Wendschlag, Gunnar Jacobs, Nathalie Kefer, Thomas Brefort, et al. 2012. “Genome-Wide miRNA Signatures of Human Longevity.” Aging Cell 11 (4): 607–16. doi:10.1111/j.1474-9726.2012.00824.x.

Emamian, Effat S., Michael D. Kaytor, Lisa A. Duvick, Tao Zu, Susan K. Tousey, Huda Y. Zoghbi, H. Brent Clark, and Harry T. Orr. 2003. “Serine 776 of Ataxin-1 Is Critical for Polyglutamine-Induced Disease in SCA1 Transgenic Mice.” Neuron 38 (3): 375–87.

Evert, B. O., I. R. Vogt, C. Kindermann, L. Ozimek, R. A. de Vos, E. R. Brunt, I. Schmitt, T. Klockgether, and U. Wüllner. 2001. “Inflammatory Genes Are Upregulated in Expanded Ataxin-3-Expressing Cell Lines and Spinocerebellar Ataxia Type 3 Brains.” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 21 (15): 5389–96.

Fenoglio, Chiara, Claudia Cantoni, Milena De Riz, Elisa Ridolfi, Francesca Cortini, Maria Serpente, Chiara Villa, et al. 2011. “Expression and Genetic Analysis of miRNAs Involved in CD4+ Cell Activation in Patients with Multiple Sclerosis.” Neuroscience Letters 504 (1): 9–12. doi:10.1016/j.neulet.2011.08.021.

Fernandez-Funez, Pedro, Maria Laura Nino-Rosales, Beatrice de Gouyon, Wei-Chi She, James M. Luchak, Pedro Martinez, Enrique Turiegano, et al. 2000. “Identification of Genes That Modify Ataxin-1-Induced Neurodegeneration.” Nature 408 (6808): 101–6. doi:10.1038/35040584.

Fernandez-Funez, P., M. L. Nino-Rosales, B. de Gouyon, W. C. She, J. M. Luchak, P. Martinez, E. Turiegano, et al. 2000. “Identification of Genes That Modify Ataxin-1-Induced Neurodegeneration.” Nature 408 (6808): 101–6. doi:10.1038/35040584.

Fraga, Mario F., Esteban Ballestar, Maria F. Paz, Santiago Ropero, Fernando Setien, Maria L. Ballestar, Damia Heine-Suñer, et al. 2005. “Epigenetic Differences Arise during the Lifetime of Monozygotic Twins.” Proceedings of the National Academy of Sciences of the United States of America 102 (30): 10604–9. doi:10.1073/pnas.0500398102.

Franceschini, Andrea, Damian Szklarczyk, Sune Frankild, Michael Kuhn, Milan Simonovic, Alexander Roth, Jianyi Lin, et al. 2013. “STRING v9.1: Protein-Protein Interaction Networks, with Increased Coverage and Integration.” Nucleic Acids Research 41 (Database issue): D808–15. doi:10.1093/nar/gks1094.

Frank-Cannon, Tamy C., Laura T. Alto, Fiona E. McAlpine, and Malú G. Tansey. 2009. “Does Neuroinflammation Fan the Flame in Neurodegenerative Diseases?” Molecular Neurodegeneration 4 (1): 47. doi:10.1186/1750-1326-4-47.

Fu, Y. H., D. P. Kuhl, A. Pizzuti, M. Pieretti, J. S. Sutcliffe, S. Richards, A. J. Verkerk, J. J. Holden, R. G. Fenwick, and S. T. Warren. 1991. “Variation of the CGG Repeat at the Fragile X Site Results in Genetic Instability: Resolution of the Sherman Paradox.” Cell 67 (6): 1047–58.

Gal, Hilah, Gopal Pandi, Andrew A. Kanner, Zvi Ram, Gila Lithwick-Yanai, Ninette Amariglio, Gideon Rechavi, and David Givol. 2008. “MIR-451 and Imatinib

!

! 143!

Mesylate Inhibit Tumor Growth of Glioblastoma Stem Cells.” Biochemical and Biophysical Research Communications 376 (1): 86–90. doi:10.1016/j.bbrc.2008.08.107.

Ganguli, Mary, Graham Ratcliff, Vijay Chandra, Sujatha Sharma, Joanne Gilby, Rajesh Pandav, Steven Belle, et al. 1995. “A Hindi Version of the MMSE: The Development of a Cognitive Screening Instrument for a Largely Illiterate Rural Elderly Population in India.” International Journal of Geriatric Psychiatry 10 (5): 367–77. doi:10.1002/gps.930100505.

Gaughwin, Philip Michael, Maciej Ciesla, Nayana Lahiri, Sarah J. Tabrizi, Patrik Brundin, and Maria Björkqvist. 2011. “Hsa-miR-34b Is a Plasma-Stable microRNA That Is Elevated in Pre-Manifest Huntington’s Disease.” Human Molecular Genetics 20 (11): 2225–37. doi:10.1093/hmg/ddr111.

Genovesi, Laura A., Kim W. Carter, Nicholas G. Gottardo, Keith M. Giles, and Peter B. Dallas. 2011. “Integrated Analysis of miRNA and mRNA Expression in Childhood Medulloblastoma Compared with Neural Stem Cells.” PloS One 6 (9): e23935. doi:10.1371/journal.pone.0023935.

Gokhale, Amit, Ratika Kunder, Atul Goel, Rajiv Sarin, Aliasgar Moiyadi, Asha Shenoy, Chandrasekhar Mamidipally, Santosh Noronha, Sadhana Kannan, and Neelam Vishwanath Shirsat. 2010. “Distinctive microRNA Signature of Medulloblastomas Associated with the WNT Signaling Pathway.” Journal of Cancer Research and Therapeutics 6 (4): 521–29. doi:10.4103/0973-1482.77072.

Goldfarb, L G, O Vasconcelos, F A Platonov, A Lunkes, V Kipnis, S Kononova, T Chabrashvili, V A Vladimirtsev, V P Alexeev, and D C Gajdusek. 1996. “Unstable Triplet Repeat and Phenotypic Variability of Spinocerebellar Ataxia Type 1.” Annals of Neurology 39 (4): 500–506. doi:10.1002/ana.410390412.

Grasso, Margherita, Paola Piscopo, Annamaria Confaloni, and Michela A. Denti. 2014. “Circulating miRNAs as Biomarkers for Neurodegenerative Disorders.” Molecules (Basel, Switzerland) 19 (5): 6891–6910. doi:10.3390/molecules19056891.

Green, Kim N., and Frank M. LaFerla. 2008. “Linking Calcium to Abeta and Alzheimer’s Disease.” Neuron 59 (2): 190–94. doi:10.1016/j.neuron.2008.07.013.

Guerreiro, Rita João, Ebba Lohmann, Emma Kinsella, José Miguel Brás, Nga Luu, Nicole Gurunlian, Burcu Dursun, et al. 2012. “Exome Sequencing Reveals an Unexpected Genetic Cause of Disease: NOTCH3 Mutation in a Turkish Family with Alzheimer’s Disease.” Neurobiology of Aging 33 (5): 1008.e17–23. doi:10.1016/j.neurobiolaging.2011.10.009.

Ha, Minju, and V. Narry Kim. 2014a. “Regulation of microRNA Biogenesis.” Nature Reviews Molecular Cell Biology 15 (8): 509–24. doi:10.1038/nrm3838.

Hannedouche, Sebastien, Valerie Beck, Juliet Leighton-Davies, Martin Beibel, Guglielmo Roma, Edward J. Oakeley, Vincent Lannoy, et al. 2013. “Identification of the C3a Receptor (C3AR1) as the Target of the VGF-Derived Peptide TLQP-21 in Rodent Cells.” The Journal of Biological Chemistry 288 (38): 27434–43. doi:10.1074/jbc.M113.497214.

Hansen, Stephen T., Pratap Meera, Thomas S. Otis, and Stefan M. Pulst. 2013. “Changes in Purkinje Cell Firing and Gene Expression Precede Behavioral Pathology in a Mouse Model of SCA2.” Human Molecular Genetics 22 (2): 271–83. doi:10.1093/hmg/dds427.

!

! 144!

Hatzikotoulas, Konstantinos, Arthur Gilly, and Eleftheria Zeggini. 2014. “Using Population Isolates in Genetic Association Studies.” Briefings in Functional Genomics 13 (5): 371–77. doi:10.1093/bfgp/elu022.

Hayashi, Hisaki, Hideto Sano, Seungwoon Seo, and Tsutomu Kume. 2008. “The Foxc2 Transcription Factor Regulates Angiogenesis via Induction of Integrin β3 Expression.” Journal of Biological Chemistry 283 (35): 23791–800. doi:10.1074/jbc.M800190200.

Hayes, S., G. Turecki, K. Brisebois, I. Lopes-Cendes, C. Gaspar, O. Riess, L. P. Ranum, S. M. Pulst, and G. A. Rouleau. 2000. “CAG Repeat Length in RAI1 Is Associated with Age at Onset Variability in Spinocerebellar Ataxia Type 2 (SCA2).” Human Molecular Genetics 9 (12): 1753–58.

Hébert, Sébastien S., Katrien Horré, Laura Nicolaï, Aikaterini S. Papadopoulou, Wim Mandemakers, Asli N. Silahtaroglu, Sakari Kauppinen, André Delacourte, and Bart De Strooper. 2008. “Loss of microRNA Cluster miR-29a/b-1 in Sporadic Alzheimer’s Disease Correlates with Increased BACE1/beta-Secretase Expression.” Proceedings of the National Academy of Sciences of the United States of America 105 (17): 6415–20. doi:10.1073/pnas.0710263105.

Hodges, Angela, Andrew D. Strand, Aaron K. Aragaki, Alexandre Kuhn, Thierry Sengstag, Gareth Hughes, Lyn A. Elliston, et al. 2006. “Regional and Cellular Gene Expression Changes in Human Huntington’s Disease Brain.” Human Molecular Genetics 15 (6): 965–77. doi:10.1093/hmg/ddl013.

Hunter, Melissa Piper, Noura Ismail, Xiaoli Zhang, Baltazar D. Aguda, Eun Joo Lee, Lianbo Yu, Tao Xiao, et al. 2008. “Detection of microRNA Expression in Human Peripheral Blood Microvesicles.” PLoS ONE 3 (11). doi:10.1371/journal.pone.0003694.

Illarioshkin, Sergei N., Pyotr A. Slominsky, Igor V. Ovchinnikov, Elena D. Markova, Natalya I. Miklina, Sergei A. Klyushnikov, Marya Shadrina, Nikolai V. Vereshchagin, Svetlana A. Limborskaya, and Irina A. Ivanova-Smolenskaya. 1996. “Spinocerebellar Ataxia Type 1 in Russia.” Journal of Neurology 243 (7): 506–10. doi:10.1007/BF00886871.

Illarioshkin, S N, P A Slominsky, I V Ovchinnikov, E D Markova, N I Miklina, S A Klyushnikov, M Shadrina, N V Vereshchagin, S A Limborskaya, and I A Ivanova-Smolenskaya. 1996. “Spinocerebellar Ataxia Type 1 in Russia.” Journal of Neurology 243 (7): 506–10.

Irwin, Stuart, Mark Vandelft, Deborah Pinchev, Jenny L. Howell, Joanna Graczyk, Harry T. Orr, and Ray Truant. 2005. “RNA Association and Nucleocytoplasmic Shuttling by Ataxin-1.” Journal of Cell Science 118 (Pt 1): 233–42. doi:10.1242/jcs.01611.

Jacobi, H., P. Bauer, P. Giunti, R. Labrum, M. G. Sweeney, P. Charles, A. Dürr, et al. 2011. “The Natural History of Spinocerebellar Ataxia Type 1, 2, 3, and 6: A 2-Year Follow-up Study.” Neurology 77 (11): 1035–41. doi:10.1212/WNL.0b013e31822e7ca0.

Jacobi, Heike, Kathrin Reetz, Sophie Tezenas du Montcel, Peter Bauer, Caterina Mariotti, Lorenzo Nanetti, Maria Rakowicz, et al. 2013. “Biological and Clinical Characteristics of Individuals at Risk for Spinocerebellar Ataxia Types 1, 2, 3, and 6 in the Longitudinal RISCA Study: Analysis of Baseline Data.” Lancet Neurology 12 (7): 650–58. doi:10.1016/S1474-4422(13)70104-2.

Jhunjhunwala, Ketan, M. Netravathi, Meera Purushottam, Sanjeev Jain, and Pramod Kumar Pal. 2013. “Profile of Extrapyramidal Manifestations in 85 Patients

!

! 145!

with Spinocerebellar Ataxia Type 1, 2 and 3.” Journal of Clinical Neuroscience. Accessed December 29. doi:10.1016/j.jocn.2013.10.021.

Jiang, Feng, Xuecheng Ye, Xiang Liu, Lauren Fincher, Dennis McKearin, and Qinghua Liu. 2005. “Dicer-1 and R3D1-L Catalyze microRNA Maturation in Drosophila.” Genes & Development 19 (14): 1674–79. doi:10.1101/gad.1334005.

Jiang, Qinghua, Yadong Wang, Yangyang Hao, Liran Juan, Mingxiang Teng, Xinjun Zhang, Meimei Li, Guohua Wang, and Yunlong Liu. 2009. “miR2Disease: A Manually Curated Database for microRNA Deregulation in Human Disease.” Nucleic Acids Research 37 (Database issue): D98–104. doi:10.1093/nar/gkn714.

Jin, Sheng Chih, Pau Pastor, Breanna Cooper, Sebastian Cervantes, Bruno A Benitez, Cristina Razquin, Alison Goate, Ibero-American Alzheimer Disease Genetics Group Researchers, and Carlos Cruchaga. 2012. “Pooled-DNA Sequencing Identifies Novel Causative Variants in PSEN1, GRN and MAPT in a Clinical Early-Onset and Familial Alzheimer’s Disease Ibero-American Cohort.” Alzheimer’s Research & Therapy 4 (4): 34. doi:10.1186/alzrt137.

Jodice, C, M Frontali, F Persichetti, A Novelletto, M Pandolfo, M Spadaro, P Giunti, G Schinaia, P Lulli, and P Malaspina. 1993. “The Gene for Spinal Cerebellar Ataxia 1 (SCA1) Is Flanked by Two Closely Linked Highly Polymorphic Microsatellite Loci.” Human Molecular Genetics 2 (9): 1383–87.

Jodice, C., P. Malaspina, F. Persichetti, A. Novelletto, M. Spadaro, P. Giunti, C. Morocutti, L. Terrenato, A. E. Harding, and M. Frontali. 1994a. “Effect of Trinucleotide Repeat Length and Parental Sex on Phenotypic Variation in Spinocerebellar Ataxia I.” American Journal of Human Genetics 54 (6): 959–65.

Jodice, C, P Malaspina, F Persichetti, A Novelletto, M Spadaro, P Giunti, C Morocutti, L Terrenato, A E Harding, and M Frontali. 1994b. “Effect of Trinucleotide Repeat Length and Parental Sex on Phenotypic Variation in Spinocerebellar Ataxia I.” American Journal of Human Genetics 54 (6): 959–65.

Ju, Hyoungseok, Hiroshi Kokubu, and Janghoo Lim. 2014. “Beyond the Glutamine Expansion: Influence of Posttranslational Modifications of Ataxin-1 in the Pathogenesis of Spinocerebellar Ataxia Type 1.” Molecular Neurobiology 50 (3): 866–74. doi:10.1007/s12035-014-8703-z.

Kanaan, Ziad, Shesh N. Rai, M. Robert Eichenberger, Christopher Barnes, Amy M. Dworkin, Clayton Weller, Eric Cohen, et al. 2012. “Differential microRNA Expression Tracks Neoplastic Progression in Inflammatory Bowel Disease-Associated Colorectal Cancer.” Human Mutation 33 (3): 551–60. doi:10.1002/humu.22021.

Kasumu, Adebimpe, and Ilya Bezprozvanny. 2012. “Deranged Calcium Signaling in Purkinje Cells and Pathogenesis in Spinocerebellar Ataxia 2 (SCA2) and Other Ataxias.” Cerebellum (London, England) 11 (3): 630–39. doi:10.1007/s12311-010-0182-9.

Kayal, Ashok K, Munindra Goswami, Marami Das, and Hussain Masaraf. 2011. “A Case of Spinocerebellar Ataxia from Ethnic Tribe of Assam.” Annals of Indian Academy of Neurology 14 (2): 122–23. doi:10.4103/0972-2327.82802.

Kay, C., N.h. Skotte, A.l. Southwell, and M.r. Hayden. 2014. “Personalized Gene Silencing Therapeutics for Huntington Disease.” Clinical Genetics 86 (1): 29–36. doi:10.1111/cge.12385.

!

! 146!

Kaytor, Michael D., Courtney E. Byam, Susan K. Tousey, Samuel D. Stevens, Huda Y. Zoghbi, and Harry T. Orr. 2005. “A Cell-Based Screen for Modulators of Ataxin-1 Phosphorylation.” Human Molecular Genetics 14 (8): 1095–1105. doi:10.1093/hmg/ddi122.

Kim, Jongpil, Keiichi Inoue, Jennifer Ishii, William B. Vanti, Sergey V. Voronov, Elizabeth Murchison, Gregory Hannon, and Asa Abeliovich. 2007. “A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons.” Science (New York, N.Y.) 317 (5842): 1220–24. doi:10.1126/science.1140481.

Klement, I. A., P. J. Skinner, M. D. Kaytor, H. Yi, S. M. Hersch, H. B. Clark, H. Y. Zoghbi, and H. T. Orr. 1998. “Ataxin-1 Nuclear Localization and Aggregation: Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice.” Cell 95 (1): 41–53.

Kocerha, Jannet, Yuhong Liu, David Willoughby, Kumaravel Chidamparam, Joseph Benito, Kate Nelson, Yan Xu, et al. 2013. “Longitudinal Transcriptomic Dysregulation in the Peripheral Blood of Transgenic Huntington’s Disease Monkeys.” BMC Neuroscience 14 (1): 88. doi:10.1186/1471-2202-14-88.

Kozomara, Ana, and Sam Griffiths-Jones. 2014. “miRBase: Annotating High Confidence microRNAs Using Deep Sequencing Data.” Nucleic Acids Research 42 (D1): D68–73. doi:10.1093/nar/gkt1181.

Krawczak, M, B Bockel, L Sandkuijl, U Thies, I Fenton, and P S Harper. 1991. “Covariate-Dependent Age-at-Onset Distributions for Huntington Disease.” American Journal of Human Genetics 49 (4): 735–45.

Krishna, Nithin, Surendra Mohan, B S Yashavantha, A Rammurthy, H B Kiran Kumar, Uma Mittal, Shivani Tyagi, et al. 2007. “SCA 1, SCA 2 & SCA 3/MJD Mutations in Ataxia Syndromes in Southern India.” The Indian Journal of Medical Research 126 (5): 465–70.

Kristiansson, Kati, Jussi Naukkarinen, and Leena Peltonen. 2008. “Isolated Populations and Complex Disease Gene Identification.” Genome Biology 9 (8): 109. doi:10.1186/gb-2008-9-8-109.

Kuhn, Alexandre, Darlene R. Goldstein, Angela Hodges, Andrew D. Strand, Thierry Sengstag, Charles Kooperberg, Kristina Becanovic, et al. 2007. “Mutant Huntingtin’s Effects on Striatal Gene Expression in Mice Recapitulate Changes Observed in Human Huntington’s Disease Brain and Do Not Differ with Mutant Huntingtin Length or Wild-Type Huntingtin Dosage.” Human Molecular Genetics 16 (15): 1845–61. doi:10.1093/hmg/ddm133.

Kumaran, Dhanya, Krishnan Balagopal, Reginald Tharmaraj, Sanjith Aaron, Kuryan George, Jayaprakash Muliyil, Ajith Sivadasan, Sumita Danda, Mathew Alexander, and Gaiti Hasan. 2014. “Genetic Characterization of Spinocerebellar Ataxia 1 in a South Indian Cohort.” BMC Medical Genetics 15 (1): 114. doi:10.1186/s12881-014-0114-5.

Kumar, Pavan, Zoltan Dezso, Crystal MacKenzie, Judy Oestreicher, Sergei Agoulnik, Michael Byrne, Francois Bernier, Mamoru Yanagimachi, Ken Aoshima, and Yoshiya Oda. 2013. “Circulating miRNA Biomarkers for Alzheimer’s Disease.” PLoS ONE 8 (7): e69807. doi:10.1371/journal.pone.0069807.

Laffita-Mesa, José Miguel, Peter O. Bauer, Vivian Kourí, Leodani Peña Serrano, Jane Roskams, Dennis Almaguer Gotay, Julio Cesar Montes Brown, et al. 2012. “Epigenetics DNA Methylation in the Core Ataxin-2 Gene Promoter: Novel Physiological and Pathological Implications.” Human Genetics 131 (4): 625–38. doi:10.1007/s00439-011-1101-y.

!

! 147!

Lavon, Iris, Daniel Zrihan, Avital Granit, Ofira Einstein, Nina Fainstein, Malkiel A. Cohen, Mikhal A. Cohen, et al. 2010. “Gliomas Display a microRNA Expression Profile Reminiscent of Neural Precursor Cells.” Neuro-Oncology 12 (5): 422–33. doi:10.1093/neuonc/nop061.

Lee, J.-M., E.M. Ramos, J.-H. Lee, T. Gillis, J.S. Mysore, M.R. Hayden, S.C. Warby, et al. 2012. “CAG Repeat Expansion in Huntington Disease Determines Age at Onset in a Fully Dominant Fashion.” Neurology 78 (10): 690–95. doi:10.1212/WNL.0b013e318249f683.

Lee, Joseph H, Sandra Barral, Rong Cheng, Inara Chacon, Vincent Santana, Jennifer Williamson, Rafael Lantigua, et al. 2008. “Age-at-Onset Linkage Analysis in Caribbean Hispanics with Familial Late-Onset Alzheimer’s Disease.” Neurogenetics 9 (1): 51–60. doi:10.1007/s10048-007-0103-3.

Lee, Yoontae, Rodney C. Samaco, Jennifer R. Gatchel, Christina Thaller, Harry T. Orr, and Huda Y. Zoghbi. 2008a. “miR-19, miR-101, and miR-130 Co-Regulate ATXN1 Levels to Potentially Modulate SCA1 Pathogenesis.” Nature Neuroscience 11 (10): 1137–39. doi:10.1038/nn.2183.

Leidinger, Petra, Christina Backes, Stephanie Deutscher, Katja Schmitt, Sabine C. Mueller, Karen Frese, Jan Haas, et al. 2013. “A Blood Based 12-miRNA Signature of Alzheimer Disease Patients.” Genome Biology 14 (7): R78. doi:10.1186/gb-2013-14-7-r78.

Leidinger, Petra, Andreas Keller, Anne Borries, Jörg Reichrath, Knuth Rass, Sven U. Jager, Hans-Peter Lenhof, and Eckart Meese. 2010. “High-Throughput miRNA Profiling of Human Melanoma Blood Samples.” BMC Cancer 10: 262. doi:10.1186/1471-2407-10-262.

Levati, Lauretta, Ester Alvino, Elena Pagani, Diego Arcelli, Patrizia Caporaso, Sergio Bondanza, Gianpiero Di Leva, et al. 2009. “Altered Expression of Selected microRNAs in Melanoma: Antiproliferative and Proapoptotic Activity of miRNA-155.” International Journal of Oncology 35 (2): 393–400.

Liang, Yu, Dana Ridzon, Linda Wong, and Caifu Chen. 2007. “Characterization of microRNA Expression Profiles in Normal Human Tissues.” BMC Genomics 8 (1): 166. doi:10.1186/1471-2164-8-166.

Lin, X, B Antalffy, D Kang, H T Orr, and H Y Zoghbi. 2000. “Polyglutamine Expansion down-Regulates Specific Neuronal Genes before Pathologic Changes in SCA1.” Nature Neuroscience 3 (2): 157–63. doi:10.1038/72101.

Lin, X., B. Antalffy, D. Kang, H. T. Orr, and H. Y. Zoghbi. 2000. “Polyglutamine Expansion down-Regulates Specific Neuronal Genes before Pathologic Changes in SCA1.” Nature Neuroscience 3 (2): 157–63. doi:10.1038/72101.

Lin, Xi, Barbara Antalffy, Dongcheul Kang, Harry T. Orr, and Huda Y. Zoghbi. 2000. “Polyglutamine Expansion down-Regulates Specific Neuronal Genes before Pathologic Changes in SCA1.” Nature Neuroscience 3 (2): 157–63. doi:10.1038/72101.

Liu, Jing, Tie-Shan Tang, Huiping Tu, Omar Nelson, Emily Herndon, Duong P. Huynh, Stefan M. Pulst, and Ilya Bezprozvanny. 2009. “Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 2.” The Journal of Neuroscience 29 (29): 9148–62. doi:10.1523/JNEUROSCI.0660-09.2009.

Liu, Rongjiao, Xinran Ma, Lingyan Xu, Dao Wang, Xiaohua Jiang, Wei Zhu, Bin Cui, Guang Ning, Dongping Lin, and Shu Wang. 2012. “Differential microRNA Expression in Peripheral Blood Mononuclear Cells from Graves’

!

! 148!

Disease Patients.” The Journal of Clinical Endocrinology and Metabolism 97 (6): E968–72. doi:10.1210/jc.2011-2982.

Li, Yang, Chengxiang Qiu, Jian Tu, Bin Geng, Jichun Yang, Tianzi Jiang, and Qinghua Cui. 2014. “HMDD v2.0: A Database for Experimentally Supported Human microRNA and Disease Associations.” Nucleic Acids Research 42 (D1): D1070–74. doi:10.1093/nar/gkt1023.

Loscher, Carol J., Karsten Hokamp, John H. Wilson, Tiansen Li, Peter Humphries, G. Jane Farrar, and Arpad Palfi. 2008. “A Common microRNA Signature in Mouse Models of Retinal Degeneration.” Experimental Eye Research 87 (6): 529–34. doi:10.1016/j.exer.2008.08.016.

Love, Michael I., Wolfgang Huber, and Simon Anders. 2014. “Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data with DESeq2.” bioRxiv, May. doi:10.1101/002832.

Luthi-Carter, Ruth, Sarah A. Hanson, Andrew D. Strand, Donald A. Bergstrom, Wanjoo Chun, Nikki L. Peters, Annette M. Woods, et al. 2002. “Dysregulation of Gene Expression in the R6/2 Model of Polyglutamine Disease: Parallel Changes in Muscle and Brain.” Human Molecular Genetics 11 (17): 1911–26.

Luthi-Carter, Ruth, Andrew D. Strand, Sarah A. Hanson, Charles Kooperberg, Gabriele Schilling, Albert R. La Spada, Diane E. Merry, et al. 2002. “Polyglutamine and Transcription: Gene Expression Changes Shared by DRPLA and Huntington’s Disease Mouse Models Reveal Context-Independent Effects.” Human Molecular Genetics 11 (17): 1927–37.

Luthi-Carter, Ruth, Andrew Strand, Nikki L. Peters, Steven M. Solano, Zane R. Hollingsworth, Anil S. Menon, Ariel S. Frey, et al. 2000. “Decreased Expression of Striatal Signaling Genes in a Mouse Model of Huntington’s Disease.” Human Molecular Genetics 9 (9): 1259–71. doi:10.1093/hmg/9.9.1259.

Mahadevan, M., C. Tsilfidis, L. Sabourin, G. Shutler, C. Amemiya, G. Jansen, C. Neville, M. Narang, J. Barceló, and K. O’Hoy. 1992. “Myotonic Dystrophy Mutation: An Unstable CTG Repeat in the 3’ Untranslated Region of the Gene.” Science (New York, N.Y.) 255 (5049): 1253–55.

Martí, Eulàlia, and Xavier Estivill. 2013. “Small Non-Coding RNAs Add Complexity to the RNA Pathogenic Mechanisms in Trinucleotide Repeat Expansion Diseases.” Frontiers in Molecular Neuroscience 6: 45. doi:10.3389/fnmol.2013.00045.

Martí, Eulàlia, Lorena Pantano, Mónica Bañez-Coronel, Franc Llorens, Elena Miñones-Moyano, Sílvia Porta, Lauro Sumoy, Isidre Ferrer, and Xavier Estivill. 2010. “A Myriad of miRNA Variants in Control and Huntington’s Disease Brain Regions Detected by Massively Parallel Sequencing.” Nucleic Acids Research 38 (20): 7219–35. doi:10.1093/nar/gkq575.

Martins, Madalena, Alexandra Rosa, Leonor C. Guedes, Benedita V. Fonseca, Kristina Gotovac, Sara Violante, Tiago Mestre, et al. 2011. “Convergence of miRNA Expression Profiling, Α-Synuclein Interacton and GWAS in Parkinson’s Disease.” PLoS ONE 6 (10): e25443. doi:10.1371/journal.pone.0025443.

Matilla, A., E. D. Roberson, S. Banfi, J. Morales, D. L. Armstrong, E. N. Burright, H. T. Orr, J. D. Sweatt, H. Y. Zoghbi, and M. M. Matzuk. 1998. “Mice Lacking Ataxin-1 Display Learning Deficits and Decreased Hippocampal Paired-Pulse

!

! 149!

Facilitation.” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 18 (14): 5508–16.

Matilla-Dueñas, Antoni, Robert Goold, and Paola Giunti. 2008. “Clinical, Genetic, Molecular, and Pathophysiological Insights into Spinocerebellar Ataxia Type 1.” The Cerebellum 7 (2): 106–14. doi:10.1007/s12311-008-0009-0.

Matilla-Dueñas, Antoni, Ivelisse Sánchez, Marc Corral-Juan, Antoni Dávalos, Ramiro Alvarez, and Pilar Latorre. 2010. “Cellular and Molecular Pathways Triggering Neurodegeneration in the Spinocerebellar Ataxias.” Cerebellum (London, England) 9 (2): 148–66. doi:10.1007/s12311-009-0144-2.

Matilla, T, V Volpini, D Genís, J Rosell, J Corral, A Dávalos, A Molins, and X Estivill. 1993a. “Presymptomatic Analysis of Spinocerebellar Ataxia Type 1 (SCA1) via the Expansion of the SCA1 CAG-Repeat in a Large Pedigree Displaying Anticipation and Parental Male Bias.” Human Molecular Genetics 2 (12): 2123–28.

Matilla, T., V. Volpini, D. Genís, J. Rosell, J. Corral, A. Dávalos, A. Molins, and X. Estivill. 1993b. “Presymptomatic Analysis of Spinocerebellar Ataxia Type 1 (SCA1) via the Expansion of the SCA1 CAG-Repeat in a Large Pedigree Displaying Anticipation and Parental Male Bias.” Human Molecular Genetics 2 (12): 2123–28.

Matsuyama, Zenjiro, Hideshi Kawakami, Hirofumi Maruyama, Hirofumi Maruyama, Yuishin Izumi, Osamu Komure, Fukashi Udaka, et al. 1997. “Molecular Features of the CAG Repeats of Spinocerebellar Ataxia 6 (SCA6).” Human Molecular Genetics 6 (8): 1283–87. doi:10.1093/hmg/6.8.1283.

McMurray, Cynthia T. 2010. “Mechanisms of Trinucleotide Repeat Instability during Human Development.” Nature Reviews. Genetics 11 (11): 786–99. doi:10.1038/nrg2828.

Mills, James D., Thomas Nalpathamkalam, Heidi I. L. Jacobs, Caroline Janitz, Daniele Merico, Pingzhao Hu, and Michael Janitz. 2013. “RNA-Seq Analysis of the Parietal Cortex in Alzheimer’s Disease Reveals Alternatively Spliced Isoforms Related to Lipid Metabolism.” Neuroscience Letters 536 (March): 90–95. doi:10.1016/j.neulet.2012.12.042.

Mittal, Uma, Sangeeta Sharma, Rupali Chopra, Kalladka Dheeraj, Pramod Kr Pal, Achal K Srivastava, and Mitali Mukerji. 2005. “Insights into the Mutational History and Prevalence of SCA1 in the Indian Population through Anchored Polymorphisms.” Human Genetics 118 (1): 107–14. doi:10.1007/s00439-005-0018-8.

Mollema, Nissa, and Harry Orr. 2013. “One Family’s Search to Explain a Fatal Neurological Disorder.” American Scientist 100 (6): 442. doi:10.1511/2013.105.442.

Moore, Daniel B., Oren Tomkins, and Itay Ben-Zion. 2013. “A Review of Primary Congenital Glaucoma in the Developing World.” Survey of Ophthalmology 58 (3): 278–85. doi:10.1016/j.survophthal.2012.11.003.

Mulvihill, David J., Kerrie Nichol Edamura, Katharine A. Hagerman, Christopher E. Pearson, and Yuh-Hwa Wang. 2005. “Effect of CAT or AGG Interruptions and CpG Methylation on Nucleosome Assembly upon Trinucleotide Repeats on Spinocerebellar Ataxia, Type 1 and Fragile X Syndrome.” Journal of Biological Chemistry 280 (6): 4498–4503. doi:10.1074/jbc.M413239200.

Murray, G. I., W. T. Melvin, W. F. Greenlee, and M. D. Burke. 2001. “Regulation, Function, and Tissue-Specific Expression of Cytochrome P450 CYP1B1.”

!

! 150!

Annual Review of Pharmacology and Toxicology 41: 297–316. doi:10.1146/annurev.pharmtox.41.1.297.

Myers, RichardH., David Goldman, EdwardD. Bird, DanielS. Sax, CarlR. Merril, Miriam Schoenfeld, and PhilipA. Wolf. 1983. “MATERNAL TRANSMISSION IN HUNTINGTON’S DISEASE.” The Lancet, Originally published as Volume 1, Issue 8318, 321 (8318): 208–10. doi:10.1016/S0140-6736(83)92587-4.

Nataf, Serge, Philip F. Stahel, Nathalie Davoust, and Scott R. Barnum. 1999. “Complement Anaphylatoxin Receptors on Neurons: New Tricks for Old Receptors?” Trends in Neurosciences 22 (9): 397–402. doi:10.1016/S0166-2236(98)01390-3.

Nayak, Annapurna, Rafia Ansar, Sunil K. Verma, Domenico Marco Bonifati, and Uday Kishore. 2011. “Huntington's Disease: An Immune Perspective.” Neurology Research International 2011 (August): e563784. doi:10.1155/2011/563784.

Noren Hooten, Nicole, Kotb Abdelmohsen, Myriam Gorospe, Ngozi Ejiogu, Alan B. Zonderman, and Michele K. Evans. 2010. “microRNA Expression Patterns Reveal Differential Expression of Target Genes with Age.” PLoS ONE 5 (5): e10724. doi:10.1371/journal.pone.0010724.

Nurul-Syakima, Alpha Mu, C. Yoke-Kqueen, A. R. Sabariah, M. S. Shiran, A. Singh, and L. Learn-Han. 2011. “Differential microRNA Expression and Identification of Putative miRNA Targets and Pathways in Head and Neck Cancers.” International Journal of Molecular Medicine 28 (3): 327–36. doi:10.3892/ijmm.2011.714.

Nussbaum, R., and G. Auburger. 2000. “Neurodegeneration in the Polyglutamine Diseases: Act 1, Scene 1.” Nature Neuroscience 3 (2): 103–4. doi:10.1038/72042.

Nuutinen, Tapio, Tiina Suuronen, Anu Kauppinen, and Antero Salminen. 2009. “Clusterin: A Forgotten Player in Alzheimer’s Disease.” Brain Research Reviews 61 (2): 89–104. doi:10.1016/j.brainresrev.2009.05.007.

Ohashi, Ryo, Shin-ichi Sakata, Asami Naito, Naohide Hirashima, and Masahiko Tanaka. 2014. “Dendritic Differentiation of Cerebellar Purkinje Cells Is Promoted by Ryanodine Receptors Expressed by Purkinje and Granule Cells.” Developmental Neurobiology 74 (4): 467–80. doi:10.1002/dneu.22139.

Okazawa, Hitoshi, Tina Rich, Alex Chang, Xi Lin, Masaaki Waragai, Masunori Kajikawa, Yasushi Enokido, et al. 2002. “Interaction between Mutant Ataxin-1 and PQBP-1 Affects Transcription and Cell Death.” Neuron 34 (5): 701–13.

Orozco Diaz, G., A. Nodarse Fleites, R. Cordovés Sagaz, and G. Auburger. 1990. “Autosomal Dominant Cerebellar Ataxia: Clinical Analysis of 263 Patients from a Homogeneous Population in Holguín, Cuba.” Neurology 40 (9): 1369–75.

Orr, Harry T. 2012a. “Cell Biology of Spinocerebellar Ataxia.” The Journal of Cell Biology 197 (2): 167–77. doi:10.1083/jcb.201105092.

———. 2012b. “SCA1-Phosphorylation, a Regulator of Ataxin-1 Function and Pathogenesis.” Progress in Neurobiology 99 (3): 179–85. doi:10.1016/j.pneurobio.2012.04.003.

Orr, H. T., M. Y. Chung, S. Banfi, T. J. Kwiatkowski, A. Servadio, A. L. Beaudet, A. E. McCall, L. A. Duvick, L. P. Ranum, and H. Y. Zoghbi. 1993a. “Expansion of an Unstable Trinucleotide CAG Repeat in Spinocerebellar Ataxia Type 1.” Nature Genetics 4 (3): 221–26. doi:10.1038/ng0793-221.

!

! 151!

Parakalan, Rangarajan, Boran Jiang, Baby Nimmi, Manivannan Janani, Manikandan Jayapal, Jia Lu, Samuel SW Tay, Eng-Ang Ling, and S. T. Dheen. 2012. “Transcriptome Analysis of Amoeboid and Ramified Microglia Isolated from the Corpus Callosum of Rat Brain.” BMC Neuroscience 13 (1): 64. doi:10.1186/1471-2202-13-64.

Pearson, Christopher E. 2003. “Slipping While Sleeping? Trinucleotide Repeat Expansions in Germ Cells.” Trends in Molecular Medicine 9 (11): 490–95.

Perkins, Emma M., Yvonne L. Clarkson, Nancy Sabatier, David M. Longhurst, Christopher P. Millward, Jennifer Jack, Junko Toraiwa, et al. 2010. “Loss of Beta-III Spectrin Leads to Purkinje Cell Dysfunction Recapitulating the Behavior and Neuropathology of Spinocerebellar Ataxia Type 5 in Humans.” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 30 (14): 4857–67. doi:10.1523/JNEUROSCI.6065-09.2010.

Persengiev, Stephan, Ivanela Kondova, Nel Otting, Arnulf H. Koeppen, and Ronald E. Bontrop. 2011a. “Genome-Wide Analysis of miRNA Expression Reveals a Potential Role for miR-144 in Brain Aging and Spinocerebellar Ataxia Pathogenesis.” Neurobiology of Aging 32 (12): 2316.e17–27. doi:10.1016/j.neurobiolaging.2010.03.014.

Persengiev, Stephan, Ivanela Kondova, Nel Otting, Arnulf H Koeppen, and Ronald E Bontrop. 2011b. “Genome-Wide Analysis of miRNA Expression Reveals a Potential Role for miR-144 in Brain Aging and Spinocerebellar Ataxia Pathogenesis.” Neurobiology of Aging 32 (12): 2316.e17–27. doi:10.1016/j.neurobiolaging.2010.03.014.

Pirnik, Z., and A. Kiss. 2002. “[The cerebellum: anatomy, distribution of mediators and their receptors, communication with hypothalamic structures and comparison with the hypothalamic paraventricular nucleus under conditions of stress].” Ceskoslovenská Fysiologie / Ústrední Ústav Biologický 51 (2): 47–60.

Pulst, S M, A Nechiporuk, T Nechiporuk, S Gispert, X N Chen, I Lopes-Cendes, S Pearlman, et al. 1996. “Moderate Expansion of a Normally Biallelic Trinucleotide Repeat in Spinocerebellar Ataxia Type 2.” Nature Genetics 14 (3): 269–76. doi:10.1038/ng1196-269.

Quan, F, J Janas, and B W Popovich. 1995. “A Novel CAG Repeat Configuration in the SCA1 Gene: Implications for the Molecular Diagnostics of Spinocerebellar Ataxia Type 1.” Human Molecular Genetics 4 (12): 2411–13.

Ramesar, R. S., S. Bardien, P. Beighton, and A. Bryer. 1997a. “Expanded CAG Repeats in Spinocerebellar Ataxia (SCA1) Segregate with Distinct Haplotypes in South African Families.” Human Genetics 100 (1): 131–37.

Ranen, N. G., O. C. Stine, M. H. Abbott, M. Sherr, A. M. Codori, M. L. Franz, N. I. Chao, A. S. Chung, N. Pleasant, and C. Callahan. 1995. “Anticipation and Instability of IT-15 (CAG)n Repeats in Parent-Offspring Pairs with Huntington Disease.” American Journal of Human Genetics 57 (3): 593–602.

Ranum, L P, M Y Chung, S Banfi, A Bryer, L J Schut, R Ramesar, L A Duvick, A McCall, S H Subramony, and L Goldfarb. 1994a. “Molecular and Clinical Correlations in Spinocerebellar Ataxia Type I: Evidence for Familial Effects on the Age at Onset.” American Journal of Human Genetics 55 (2): 244–52.

Ranum, L. P., M. Y. Chung, S. Banfi, A. Bryer, L. J. Schut, R. Ramesar, L. A. Duvick, A. McCall, S. H. Subramony, and L. Goldfarb. 1994b. “Molecular and Clinical Correlations in Spinocerebellar Ataxia Type I: Evidence for

!

! 152!

Familial Effects on the Age at Onset.” American Journal of Human Genetics 55 (2): 244–52.

Reetz, Kathrin, Ana S Costa, Shahram Mirzazade, Anna Lehmann, Agnes Juzek, Maria Rakowicz, Romana Boguslawska, et al. 2013. “Genotype-Specific Patterns of Atrophy Progression Are More Sensitive than Clinical Decline in SCA1, SCA3 and SCA6.” Brain: A Journal of Neurology 136 (Pt 3): 905–17. doi:10.1093/brain/aws369.

Rengaraj, R, M Dhanaraj, T Arulmozhi, B Chattopadhyay, and N P Battacharyya. 2005. “High Prevalence of Spinocerebellar Ataxia Type 1 in an Ethnic Tamil Community in India.” Neurology India 53 (3): 308–10; discussion 311.

Robinson, Mark D., Davis J. McCarthy, and Gordon K. Smyth. 2010. “edgeR: A Bioconductor Package for Differential Expression Analysis of Digital Gene Expression Data.” Bioinformatics (Oxford, England) 26 (1): 139–40. doi:10.1093/bioinformatics/btp616.

Robinson, Mark D., and Alicia Oshlack. 2010. “A Scaling Normalization Method for Differential Expression Analysis of RNA-Seq Data.” Genome Biology 11 (3): R25. doi:10.1186/gb-2010-11-3-r25.

Rodriguez-Lebron, Edgardo, Gumei Liu, Megan Keiser, Mark A. Behlke, and Beverly L. Davidson. 2013a. “Altered Purkinje Cell miRNA Expression and SCA1 Pathogenesis.” Neurobiology of Disease 54 (June): 456–63. doi:10.1016/j.nbd.2013.01.019.

Rodriguez-Lebron, Edgardo, Gumei Liu, Megan Keiser, Mark A Behlke, and Beverly L Davidson. 2013b. “Altered Purkinje Cell miRNA Expression and SCA1 Pathogenesis.” Neurobiology of Disease 54 (June): 456–63. doi:10.1016/j.nbd.2013.01.019.

Ross, Christopher A., and Sergey S. Akimov. 2014. “Human-Induced Pluripotent Stem Cells: Potential for Neurodegenerative Diseases.” Human Molecular Genetics, May, ddu204. doi:10.1093/hmg/ddu204.

Rüb, Udo, Ludger Schöls, Henry Paulson, Georg Auburger, Pawel Kermer, Joanna C. Jen, Kay Seidel, Horst-Werner Korf, and Thomas Deller. 2013a. “Clinical Features, Neurogenetics and Neuropathology of the Polyglutamine Spinocerebellar Ataxias Type 1, 2, 3, 6 and 7.” Progress in Neurobiology 104 (May): 38–66. doi:10.1016/j.pneurobio.2013.01.001.

Runne, Heike, Alexandre Kuhn, Edward J. Wild, Wirahpati Pratyaksha, Mark Kristiansen, Jeremy D. Isaacs, Etienne Régulier, Mauro Delorenzi, Sarah J. Tabrizi, and Ruth Luthi-Carter. 2007a. “Analysis of Potential Transcriptomic Biomarkers for Huntington’s Disease in Peripheral Blood.” Proceedings of the National Academy of Sciences of the United States of America 104 (36): 14424–29. doi:10.1073/pnas.0703652104.

Runne, Heike, Etienne Régulier, Alexandre Kuhn, Diana Zala, Ozgun Gokce, Valérie Perrin, Beate Sick, Patrick Aebischer, Nicole Déglon, and Ruth Luthi-Carter. 2008. “Dysregulation of Gene Expression in Primary Neuron Models of Huntington’s Disease Shows That Polyglutamine-Related Effects on the Striatal Transcriptome May Not Be Dependent on Brain Circuitry.” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 28 (39): 9723–31. doi:10.1523/JNEUROSCI.3044-08.2008.

Saito, Yoshimasa, Gangning Liang, Gerda Egger, Jeffrey M. Friedman, Jody C. Chuang, Gerhard A. Coetzee, and Peter A. Jones. 2006. “Specific Activation of microRNA-127 with Downregulation of the Proto-Oncogene BCL6 by

!

! 153!

Chromatin-Modifying Drugs in Human Cancer Cells.” Cancer Cell 9 (6): 435–43. doi:10.1016/j.ccr.2006.04.020.

Saleem, Q, S Choudhry, M Mukerji, L Bashyam, M V Padma, A Chakravarthy, M C Maheshwari, S Jain, and S K Brahmachari. 2000. “Molecular Analysis of Autosomal Dominant Hereditary Ataxias in the Indian Population: High Frequency of SCA2 and Evidence for a Common Founder Mutation.” Human Genetics 106 (2): 179–87.

Sánchez, Ivelisse, Patricia Piñol, Marc Corral-Juan, Massimo Pandolfo, and Antoni Matilla-Dueñas. 2013. “A Novel Function of Ataxin-1 in the Modulation of PP2A Activity Is Dysregulated in the Spinocerebellar Ataxia Type 1.” Human Molecular Genetics, April, ddt197. doi:10.1093/hmg/ddt197.

Sasaki, H., T. Fukazawa, T. Yanagihara, T. Hamada, K. Shima, A. Matsumoto, K. Hashimoto, N. Ito, A. Wakisaka, and K. Tashiro. 1996. “Clinical Features and Natural History of Spinocerebellar Ataxia Type 1.” Acta Neurologica Scandinavica 93 (1): 64–71.

Schaefer, Anne, Dónal O’Carroll, Chan Lek Tan, Dean Hillman, Mutsuyuki Sugimori, Rodolfo Llinas, and Paul Greengard. 2007. “Cerebellar Neurodegeneration in the Absence of microRNAs.” The Journal of Experimental Medicine 204 (7): 1553–58. doi:10.1084/jem.20070823.

Scherzer, Clemens R., Roderick V. Jensen, Steven R. Gullans, and Mel B. Feany. 2003. “Gene Expression Changes Presage Neurodegeneration in a Drosophila Model of Parkinson’s Disease.” Human Molecular Genetics 12 (19): 2457–66. doi:10.1093/hmg/ddg265.

Schipper, Hyman M., Olivier C. Maes, Howard M. Chertkow, and Eugenia Wang. 2007. “MicroRNA Expression in Alzheimer Blood Mononuclear Cells.” Gene Regulation and Systems Biology 1 (December): 263–74.

Schmitz-Hubsch T. 2006. “Scale for the Assessment and Rating of Ataxia: Development of a New Clinical Scale.” Neurology 67 (2): 299–299 – b. doi:10.1212/01.wnl.0000237953.63630.a6.

Schöls, Ludger, Ana Maria Menezes Vieira-Saecker, Stephan Schöls, Horst Przuntek, Jörg T. Epplen, and Olaf Riess. 1995. “Trinucleotide Expansion within the MJD1 Gene Presents Clinically as Spinocerebellar Ataxia and Occurs Most Frequently in German SCA Patients.” Human Molecular Genetics 4 (6): 1001–5. doi:10.1093/hmg/4.6.1001.

Schorge, Stephanie, Joyce van de Leemput, Andrew Singleton, Henry Houlden, and John Hardy. 2010. “Human Ataxias: A Genetic Dissection of Inositol Triphosphate Receptor (ITPR1)-Dependent Signaling.” Trends in Neurosciences 33 (5): 211–19. doi:10.1016/j.tins.2010.02.005.

Schultz, Julia, Peter Lorenz, Gerd Gross, Saleh Ibrahim, and Manfred Kunz. 2008. “MicroRNA Let-7b Targets Important Cell Cycle Molecules in Malignant Melanoma Cells and Interferes with Anchorage-Independent Growth.” Cell Research 18 (5): 549–57. doi:10.1038/cr.2008.45.

SCHUT JW. 1950. “Hereditary Ataxia: Clinical Study through Six Generations.” Archives of Neurology & Psychiatry 63 (4): 535–68. doi:10.1001/archneurpsyc.1950.02310220002001.

Seredenina, Tamara, and Ruth Luthi-Carter. 2012. “What Have We Learned from Gene Expression Profiles in Huntington’s Disease?” Neurobiology of Disease, Assessment of Gene Expression in Neuropsychiatric Disease, 45 (1): 83–98. doi:10.1016/j.nbd.2011.07.001.

!

! 154!

Serra, Heliane G., Courtney E. Byam, Jeffrey D. Lande, Susan K. Tousey, Huda Y. Zoghbi, and Harry T. Orr. 2004a. “Gene Profiling Links SCA1 Pathophysiology to Glutamate Signaling in Purkinje Cells of Transgenic Mice.” Human Molecular Genetics 13 (20): 2535–43. doi:10.1093/hmg/ddh268.

Servadio, A., B. Koshy, D. Armstrong, B. Antalffy, H. T. Orr, and H. Y. Zoghbi. 1995. “Expression Analysis of the Ataxin-1 Protein in Tissues from Normal and Spinocerebellar Ataxia Type 1 Individuals.” Nature Genetics 10 (1): 94–98. doi:10.1038/ng0595-94.

Seyednasrollah, Fatemeh, Asta Laiho, and Laura L. Elo. 2013. “Comparison of Software Packages for Detecting Differential Expression in RNA-Seq Studies.” Briefings in Bioinformatics, December. doi:10.1093/bib/bbt086.

Shakkottai, Vikram G., and Brent L. Fogel. 2013. “Clinical Neurogenetics: Autosomal Dominant Spinocerebellar Ataxia.” Neurologic Clinics, Clinical Neurogenetics, 31 (4): 987–1007. doi:10.1016/j.ncl.2013.04.006.

Shawky, Rabah M. 2014. “Reduced Penetrance in Human Inherited Disease.” Egyptian Journal of Medical Human Genetics 15 (2): 103–11. doi:10.1016/j.ejmhg.2014.01.003.

Sheinerman, Kira S., Vladimir G. Tsivinsky, Fiona Crawford, Michael J. Mullan, Laila Abdullah, and Samuil R. Umansky. 2012. “Plasma microRNA Biomarkers for Detection of Mild Cognitive Impairment.” Aging 4 (9): 590–605.

Shimono, Yohei, Maider Zabala, Robert W. Cho, Neethan Lobo, Piero Dalerba, Dalong Qian, Maximilian Diehn, et al. 2009a. “Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells.” Cell 138 (3): 592–603. doi:10.1016/j.cell.2009.07.011.

Shi, Yuting, Fengzhen Huang, Beisha Tang, Jiada Li, Junling Wang, Lu Shen, Kun Xia, and Hong Jiang. 2014. “MicroRNA Profiling in the Serums of SCA3/MJD Patients.” The International Journal of Neuroscience 124 (2): 97–101. doi:10.3109/00207454.2013.827679.

Sinha, K K, P F Worth, D K Jha, S Sinha, V J Stinton, M B Davis, N W Wood, M G Sweeney, and K P Bhatia. 2004. “Autosomal Dominant Cerebellar Ataxia: SCA2 Is the Most Frequent Mutation in Eastern India.” Journal of Neurology, Neurosurgery, and Psychiatry 75 (3): 448–52.

Smith, D C, A Bryer, L M Watson, and L J Greenberg. 2012. “Inherited Polyglutamine Spinocerebellar Ataxias in South Africa.” South African Medical Journal 102 (8). doi:10.7196/samj.5521.

Sobczak, Krzysztof, and Wlodzimierz J. Krzyzosiak. 2004. “Patterns of CAG Repeat Interruptions in SCA1 and SCA2 Genes in Relation to Repeat Instability.” Human Mutation 24 (3): 236–47. doi:10.1002/humu.20075.

Sonntag, Kai-Christian. 2010. “MicroRNAs and Deregulated Gene Expression Networks in Neurodegeneration.” Brain Research 1338 (June): 48–57. doi:10.1016/j.brainres.2010.03.106.

Soreq, Lilach, Nathan Salomonis, Michal Bronstein, David S. Greenberg, Zvi Israel, Hagai Bergman, and Hermona Soreq. 2013. “Small RNA Sequencing-Microarray Analyses in Parkinson Leukocytes Reveal Deep Brain Stimulation-Induced Splicing Changes That Classify Brain Region Transcriptomes.” Frontiers in Molecular Neuroscience 6: 10. doi:10.3389/fnmol.2013.00010.

!

! 155!

Spadaro, Dr M., P. Giunti, G. B. Colazza, F. Naso, F. Bianco, and C. Morocutti. 1993. “Clinical Study of Large Kindreds with Autosomal Dominant HLA-Linked Spinocerebellar Ataxia (SCA1) of Late Onset.” The Italian Journal of Neurological Sciences 14 (1): 17–21. doi:10.1007/BF02339038.

Spadaro, M, P Giunti, G B Colazza, F Naso, F Bianco, and C Morocutti. 1993. “Clinical Study of Large Kindreds with Autosomal Dominant HLA-Linked Spinocerebellar Ataxia (SCA1) of Late Onset.” Italian Journal of Neurological Sciences 14 (1): 17–21.

Srinivasan, Sujaya, Irene Rosita Pia Patric, and Kumaravel Somasundaram. 2011. “A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma.” PloS One 6 (3): e17438. doi:10.1371/journal.pone.0017438.

Strand, Andrew D., Aaron K. Aragaki, Dennis Shaw, Thomas Bird, Janice Holton, Christopher Turner, Stephen J. Tapscott, et al. 2005. “Gene Expression in Huntington’s Disease Skeletal Muscle: A Potential Biomarker.” Human Molecular Genetics 14 (13): 1863–76. doi:10.1093/hmg/ddi192.

Sultan, Fahad, and Mitchel Glickstein. 2007. “The Cerebellum: Comparative and Animal Studies.” Cerebellum (London, England) 6 (3): 168–76. doi:10.1080/14734220701332486.

Szklo, Moyses. 1998. “Population-Based Cohort Studies.” Epidemiologic Reviews 20 (1): 81–90.

Tang, Tie-Shan, Elizabeth Slow, Vitalie Lupu, Irina G. Stavrovskaya, Mutsuyuki Sugimori, Rodolfo Llinás, Bruce S. Kristal, Michael R. Hayden, and Ilya Bezprozvanny. 2005. “Disturbed Ca2+ Signaling and Apoptosis of Medium Spiny Neurons in Huntington’s Disease.” Proceedings of the National Academy of Sciences of the United States of America 102 (7): 2602–7. doi:10.1073/pnas.0409402102.

Tang, Tie-Shan, Huiping Tu, Edmond Y. W. Chan, Anton Maximov, Zhengnan Wang, Cheryl L. Wellington, Michael R. Hayden, and Ilya Bezprozvanny. 2003. “Huntingtin and Huntingtin-Associated Protein 1 Influence Neuronal Calcium Signaling Mediated by Inositol-(1,4,5) Triphosphate Receptor Type 1.” Neuron 39 (2): 227–39.

Tan, Lin, Jin-Tai Yu, and Lan Tan. 2014. “Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.” Molecular Neurobiology, June. doi:10.1007/s12035-014-8803-9.

Thambisetty, Madhav, Andrew Simmons, Latha Velayudhan, Abdul Hye, James Campbell, Yi Zhang, Lars-Olof Wahlund, et al. 2010. “Association of Plasma Clusterin Concentration with Severity, Pathology, and Progression in Alzheimer Disease.” Archives of General Psychiatry 67 (7): 739–48. doi:10.1001/archgenpsychiatry.2010.78.

Thathiah, Amantha, and Bart De Strooper. 2011a. “The Role of G Protein-Coupled Receptors in the Pathology of Alzheimer’s Disease.” Nature Reviews Neuroscience 12 (2): 73–87. doi:10.1038/nrn2977.

Thathiah, Amantha, Katrien Horre, An Snellinx, Elke Vandewyer, Yunhong Huang, Gerdien De Kloe, Sebastian Munck, and Bart De Strooper. 2013. “Beta-Arrestin 2 Regulates GPCR Dysfunction in Alzheimer’s Disease.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 9 (4): P531. doi:10.1016/j.jalz.2013.04.273.

Thiele, Holger, and Peter Nürnberg. 2005. “HaploPainter: A Tool for Drawing Pedigrees with Complex Haplotypes.” Bioinformatics 21 (8): 1730–32. doi:10.1093/bioinformatics/bth488.

!

! 156!

Tian, Yuan, Yang Nan, Lei Han, Anling Zhang, Guangxiu Wang, Zhifan Jia, Jianwei Hao, Peiyu Pu, Yue Zhong, and Chunsheng Kang. 2012. “MicroRNA miR-451 Downregulates the PI3K/AKT Pathway through CAB39 in Human Glioma.” International Journal of Oncology 40 (4): 1105–12. doi:10.3892/ijo.2011.1306.

Toung, Jonathan M., Michael Morley, Mingyao Li, and Vivian G. Cheung. 2011. “RNA-Sequence Analysis of Human B-Cells.” Genome Research 21 (6): 991–98. doi:10.1101/gr.116335.110.

Träger, Ulrike, Anna Magnusson, Nayana Lahiri Swales, Edward Wild, Janet North, Mark Lowdell, and Maria Björkqvist. 2013. “JAK/STAT Signalling in Huntington’s Disease Immune Cells.” PLoS Currents. doi:10.1371/currents.hd.5791c897b5c3bebeed93b1d1da0c0648.

Trapnell, Cole, David G. Hendrickson, Martin Sauvageau, Loyal Goff, John L. Rinn, and Lior Pachter. 2013. “Differential Analysis of Gene Regulation at Transcript Resolution with RNA-Seq.” Nature Biotechnology 31 (1): 46–53. doi:10.1038/nbt.2450.

Trapnell, Cole, Adam Roberts, Loyal Goff, Geo Pertea, Daehwan Kim, David R. Kelley, Harold Pimentel, Steven L. Salzberg, John L. Rinn, and Lior Pachter. 2012. “Differential Gene and Transcript Expression Analysis of RNA-Seq Experiments with TopHat and Cufflinks.” Nature Protocols 7 (3): 562–78. doi:10.1038/nprot.2012.016.

Trougakos, Ioannis P., and Efstathios S. Gonos. 2002. “Clusterin/apolipoprotein J in Human Aging and Cancer.” The International Journal of Biochemistry & Cell Biology 34 (11): 1430–48.

Tsai, Chih-Cheng, Hung-Ying Kao, Akifumi Mitzutani, Ester Banayo, Harini Rajan, Michael McKeown, and Ronald M. Evans. 2004. “Ataxin 1, a SCA1 Neurodegenerative Disorder Protein, Is Functionally Linked to the Silencing Mediator of Retinoid and Thyroid Hormone Receptors.” Proceedings of the National Academy of Sciences of the United States of America 101 (12): 4047–52. doi:10.1073/pnas.0400615101.

Van de Leemput, Joyce, Jayanth Chandran, Melanie A. Knight, Lynne A. Holtzclaw, Sonja Scholz, Mark R. Cookson, Henry Houlden, et al. 2007. “Deletion at ITPR1 Underlies Ataxia in Mice and Spinocerebellar Ataxia 15 in Humans.” PLoS Genetics 3 (6): e108. doi:10.1371/journal.pgen.0030108.

Van der Flier, A., and A. Sonnenberg. 2001. “Function and Interactions of Integrins.” Cell and Tissue Research 305 (3): 285–98.

Van de Warrenburg, Bart P C, Harrie Hendriks, Alexandra Dürr, Martin C A van Zuijlen, Giovanni Stevanin, Agnès Camuzat, Richard J Sinke, Alexis Brice, and Berry P H Kremer. 2005. “Age at Onset Variance Analysis in Spinocerebellar Ataxias: A Study in a Dutch-French Cohort.” Annals of Neurology 57 (4): 505–12. doi:10.1002/ana.20424.

Varela, Miguel A., Thomas C. Roberts, and Matthew J. A. Wood. 2013. “Epigenetics and ncRNAs in Brain Function and Disease: Mechanisms and Prospects for Therapy.” Neurotherapeutics 10 (4): 621–31. doi:10.1007/s13311-013-0212-7.

Vaz, Candida, Hafiz M. Ahmad, Pratibha Sharma, Rashi Gupta, Lalit Kumar, Ritu Kulshreshtha, and Alok Bhattacharya. 2010. “Analysis of microRNA Transcriptome by Deep Sequencing of Small RNA Libraries of Peripheral Blood.” BMC Genomics 11 (1): 288. doi:10.1186/1471-2164-11-288.

!

! 157!

Vig, P. J., S. H. Subramony, and D. O. McDaniel. 2001. “Calcium Homeostasis and Spinocerebellar Ataxia-1 (SCA-1).” Brain Research Bulletin 56 (3-4): 221–25.

Vlachos, Ioannis S., Nikos Kostoulas, Thanasis Vergoulis, Georgios Georgakilas, Martin Reczko, Manolis Maragkakis, Maria D. Paraskevopoulou, Kostantinos Prionidis, Theodore Dalamagas, and Artemis G. Hatzigeorgiou. 2012. “DIANA miRPath v.2.0: Investigating the Combinatorial Effect of microRNAs in Pathways.” Nucleic Acids Research 40 (Web Server issue): W498–504. doi:10.1093/nar/gks494.

Voogd, J., and M. Glickstein. 1998. “The Anatomy of the Cerebellum.” Trends in Neurosciences 21 (9): 370–75.

Wakisaka, A, H Sasaki, A Takada, T Fukazawa, Y Suzuki, T Hamada, K Iwabuchi, K Tashiro, and T Yoshiki. 1995. “Spinocerebellar Ataxia 1 (SCA1) in the Japanese in Hokkaido May Derive from a Single Common Ancestry.” Journal of Medical Genetics 32 (8): 590–92.

Watase, Kei, Edwin J. Weeber, Bisong Xu, Barbara Antalffy, Lisa Yuva-Paylor, Kouichi Hashimoto, Masanobu Kano, et al. 2002. “A Long CAG Repeat in the Mouse Sca1 Locus Replicates SCA1 Features and Reveals the Impact of Protein Solubility on Selective Neurodegeneration.” Neuron 34 (6): 905–19. doi:10.1016/S0896-6273(02)00733-X.

Whaley, Nathaniel Robb, Shinsuke Fujioka, and Zbigniew K. Wszolek. 2011. “Autosomal Dominant Cerebellar Ataxia Type I: A Review of the Phenotypic and Genotypic Characteristics.” Orphanet Journal of Rare Diseases 6: 33. doi:10.1186/1750-1172-6-33.

Xia, Guangbin, Katherine Santostefano, Takashi Hamazaki, Jilin Liu, S. H. Subramony, Naohiro Terada, and Tetsuo Ashizawa. 2013. “Generation of Human-Induced Pluripotent Stem Cells to Model Spinocerebellar Ataxia Type 2 in Vitro.” Journal of Molecular Neuroscience: MN 51 (2): 237–48. doi:10.1007/s12031-012-9930-2.

Yue, Shinji, Heliane G. Serra, Huda Y. Zoghbi, and Harry T. Orr. 2001. “The Spinocerebellar Ataxia Type 1 Protein, Ataxin-1, Has RNA-Binding Activity That Is Inversely Affected by the Length of Its Polyglutamine Tract.” Human Molecular Genetics 10 (1): 25–30. doi:10.1093/hmg/10.1.25.

Yue, S., H. G. Serra, H. Y. Zoghbi, and H. T. Orr. 2001. “The Spinocerebellar Ataxia Type 1 Protein, Ataxin-1, Has RNA-Binding Activity That Is Inversely Affected by the Length of Its Polyglutamine Tract.” Human Molecular Genetics 10 (1): 25–30.

Yu, Lei, Nevins W. Todd, Lingxiao Xing, Ying Xie, Howard Zhang, Zhenqiu Liu, Hongbin Fang, Jian Zhang, Ruth L. Katz, and Feng Jiang. 2010. “Early Detection of Lung Adenocarcinoma in Sputum by a Panel of microRNA Markers.” International Journal of Cancer. Journal International Du Cancer 127 (12): 2870–78. doi:10.1002/ijc.25289.

Zabel, Claus, Lei Mao, Ben Woodman, Michael Rohe, Maik A. Wacker, Yvonne Kläre, Andrea Koppelstätter, et al. 2009. “A Large Number of Protein Expression Changes Occur Early in Life and Precede Phenotype Onset in a Mouse Model for Huntington Disease.” Molecular & Cellular Proteomics: MCP 8 (4): 720–34. doi:10.1074/mcp.M800277-MCP200.

Zhou, Y X, W H Qiao, W H Gu, H Xie, B S Tang, L S Zhou, B X Yang, et al. 2001. “Spinocerebellar Ataxia Type 1 in China: Molecular Analysis and Genotype-Phenotype Correlation in 5 Families.” Archives of Neurology 58 (5): 789–94.

!

! 158!

Zhuchenko, O., J. Bailey, P. Bonnen, T. Ashizawa, D. W. Stockton, C. Amos, W. B. Dobyns, S. H. Subramony, H. Y. Zoghbi, and C. C. Lee. 1997. “Autosomal Dominant Cerebellar Ataxia (SCA6) Associated with Small Polyglutamine Expansions in the Alpha 1A-Voltage-Dependent Calcium Channel.” Nature Genetics 15 (1): 62–69. doi:10.1038/ng0197-62.

Zoghbi, Huda Y., and Harry T. Orr. 2009a. “Pathogenic Mechanisms of a Polyglutamine-Mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1.” The Journal of Biological Chemistry 284 (12): 7425–29. doi:10.1074/jbc.R800041200.

Zoghbi, H. Y., and H. T. Orr. 2000. “Glutamine Repeats and Neurodegeneration.” Annual Review of Neuroscience 23: 217–47. doi:10.1146/annurev.neuro.23.1.217.

Zoghbi, H. Y., M. S. Pollack, L. A. Lyons, R. E. Ferrell, S. P. Daiger, and A. L. Beaudet. 1988. “Spinocerebellar Ataxia: Variable Age of Onset and Linkage to Human Leukocyte Antigen in a Large Kindred.” Annals of Neurology 23 (6): 580–84. doi:10.1002/ana.410230609.